FGIHIGH SIGNALFINANCIAL10-K

FGI exhibits severe financial deterioration with cash reserves declining by nearly 60% and a dramatic reduction in outstanding shares from 9.6 million to 1.9 million.

The massive share count reduction suggests either a significant reverse stock split or major buyback program, while the cash burn pattern indicates potential liquidity stress. The company's operational losses are worsening despite reduced R&D spending, pointing to fundamental business challenges that require immediate investor attention.

Comparing 2026-04-10 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

FGI's financial position has deteriorated markedly, with cash and equivalents falling from $4.6M to $1.9M while operating losses deepened from -$2.1M to -$2.4M. The company reduced capital expenditures substantially and cut R&D expenses, suggesting cost conservation measures amid cash constraints. The dramatic 80% reduction in share count combined with declining stockholders' equity and rising interest expenses signals significant financial restructuring activity that warrants close monitoring.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
-59.8%
$2.2M$886K

Capex reduced 59.8% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Cash & Equivalents
Balance Sheet
-58.7%
$4.6M$1.9M

Cash declined 58.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Accounts Receivable
Balance Sheet
-31.8%
$20.3M$13.8M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Interest Expense
P&L
+24.8%
$601K$750K

Interest costs rose 24.8% — monitor debt levels and coverage ratio in rising rate environment.

Stockholders Equity
Balance Sheet
-22.3%
$22.3M$17.3M

Equity decreased 22.3% — buybacks or losses reducing book value, monitor solvency ratios.

R&D Expense
P&L
-16.6%
$1.7M$1.4M

R&D spending cut 16.6% — could signal cost discipline or concerning reduction in innovation investment.

Operating Income
P&L
-14.4%
-$2.1M-$2.4M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

LANGUAGE CHANGES
NEW — 2026-04-10
PRIOR — 2025-03-31
ADDED
As of April 6, 2026, the registrant had 1,927,326 outstanding ordinary shares.
Global or regional unrest, conflict (such as the hostilities in the Middle East and the war between Russia and Ukraine), geopolitical disputes or catastrophic events could affect global trade routes, financial markets, global economic activity and our operations and results of operations.
Litigation and Regulatory Risks We are currently involved in legal proceedings and may in the future be a party to additional claims and litigation, which could be costly and divert significant resources.
Our brand and category makeup of our net sales is as follows: BRANDS MAIN PRODUCT CATEGORIES PRODUCT OFFERINGS Sanitaryware .
bath and kitchen markets is estimated to be approximately $228 billion in 2026, of which approximately half is in product categories that we currently operate within.
+7 more — sign up free →
REMOVED
As of March 26, 2025, the registrant had 9,589,503 outstanding ordinary shares.
We have been and may continue to be subject to cybersecurity attacks, which could adversely affect our results of operations and financial position.
Our Products We offer a wide variety of products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other.
As a result of the increased significance of shower systems in our product portfolio, the Company has created a standalone Shower Systems product category in 2023, as detailed below.
The Other category continues to comprise our kitchen cabinetry and other smaller offerings.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →